Eli Lilly Shares Sink, Qualcomm's Tepid Forecast, Carrier Global Rises

On this episode of Stock Movers:

- Eli Lilly (LLY) shares fell the most intraday since October after CVS Health announced a plan to drop its blockbuster weight-loss drug Zepbound from its preferred list, making rival Wegovy more widely available. While the company maintained its sales guidance between $58 billion and $61 billion for the year, and Zepbound performed in line with Wall Street’s expectations, investors who had been hoping for more explosive growth were underwhelmed.

- Qualcomm (QCOM) shares fell after the company gave a tepid revenue forecast, underscoring concerns that tariffs will hurt demand for its products. Revenue in the period ending in June will be $9.9 billion to $10.7 billion, the company said Wednesday in a statement. The midpoint of that range was slightly below the average analyst estimate of $10.33 billion.

- Carrier Global Corp. (CARR) shares are up. The company said said its tariff exposure has been alleviated in part through price increases, allowing it to boost its full-year profit outlook and sending its shares higher. The HVAC company is fully mitigating the impact of tariffs that are in effect today, it said in a statement Thursday. “We are fully mitigating our tariff exposure through supply chain and productivity actions with the balance of about $300 million via price, which represents a little over 1% of additional pricing,” Chief Executive Officer Dave Gitlin said on a call with investors.

See omnystudio.com/listener for privacy information.